Latest News about NVO
Recent news which mentions NVO
Eli Lilly, Novo Nordisk Could Be First Trillion-Dollar Drug Stocks
February 06, 2024
From InvestorPlace
Why Catalent Stock Soared Today
February 05, 2024
From Motley Fool
Why Novo Nordisk Stock Crushed the Market on Monday
February 05, 2024
From Motley Fool
NVO, LLY or AZN: Which Pharma Stock Is the Best Weight-Loss Investment?
February 05, 2024
From InvestorPlace
Stocks Fall As Traders Dial Back Rate Cut Bets; Dollar, Treasury Yields Rise: What's Driving Markets Monday?
February 05, 2024
From Benzinga
What's Going On With Eli Lilly Stock Today?
February 05, 2024
From Benzinga
Catalent (CTLT) Stock Pops 10% on Sale to Novo Nordisk
February 05, 2024
From InvestorPlace
Ozempic Maker Strikes $11B Deal With Catalent As It Rushes To Meet Massive Weight-Loss Drug Demand
February 05, 2024
From Benzinga
Is Novo Nordisk a Hot Stock to Buy Now After its Spectacular Q4?
February 05, 2024
Tickers
NVO
From Motley Fool
After a 90% Gain, Is It Too Late to Buy Eli Lilly?
February 04, 2024
From Motley Fool
Deep Dive Into Novo Nordisk Stock: Analyst Perspectives (4 Ratings)
February 01, 2024
Tickers
NVO
From Benzinga
The Road to a Trillion: 3 Stocks Next in Line for the Mega Milestone
February 01, 2024
From InvestorPlace
Why Eli Lilly Stock Topped the Market Today
January 31, 2024
From Motley Fool
Take Your Ozempic: Why Late Entry Of Rival Weight-Loss Drugs Won't Floor Novo, Eli Shares
January 31, 2024
From Benzinga
With Bumper $33B Sales, Novo Nordisk Forecasts Double-Digit 2024 Earnings Growth, Boosts Lower Dose Wegovy US Supplies
January 31, 2024
From Benzinga
Novo Nordisk Skyrockets To $506B Valuation Driven By 'Miracle' Drugs Ozempic, Wegovy
January 31, 2024
From Benzinga
Earnings Scheduled For January 31, 2024
January 31, 2024
From Benzinga
Will Novo Nordisk Be a $1 Trillion Company by 2030?
January 30, 2024
From Motley Fool
Eli Lilly Wants to Expand Access to Weight-Loss Treatments In Germany, In Talks With Government
January 29, 2024
From Benzinga
If You Invested $5,000 in Novo Nordisk in 2019, This Is How Much You Would Have Today
January 27, 2024
From Motley Fool
Could Eli Lilly Be a Trillion-Dollar Company by 2030?
January 27, 2024
From Motley Fool
Novo Nordisk Options Trading: A Deep Dive into Market Sentiment
January 26, 2024
Tickers
NVO
From Benzinga
Eli Lilly's Famed Obesity And Diabetes Drug, Mounjaro, Comes To UK Patients, Wins Regulatory Clearance For Prefilled Injection Pen
January 25, 2024
From Benzinga
5 Mega-Cap Stocks Ready to Make the Magnificent 7 a Dynamic Dozen
January 25, 2024
From InvestorPlace
Weight Loss Drug's Ozempic Counterfeit: Rising Reports Over Patient Safety Related Fake Drugs
January 24, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.